Bey P, Jung M J, Koch-Weser J, Palfreyman M G, Sjoerdsma A, Wagner J, Zraïka M
Br J Pharmacol. 1980 Dec;70(4):571-6. doi: 10.1111/j.1476-5381.1980.tb09776.x.
1 alpha-Monofluoromethyldopa (MFMD, RMI 71963), a potent and selective enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase produces a substantial and long-lasting decrease in the catecholamine content of mouse brain, heart and kidney. 2 Single doses of MFMD reduce the 5-hydroxytryptamine concentration of mouse brain without altering the tryptophan concentration. 3 In animals treated with MFMD, peripheral but not brain noradrenaline is restored within 1 h to control levels by an intraperitoneal injection of dopamine.